Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Gelfond, Rebecca J.	en_US
dc.date.accessioned	2012-06-07T04:25:14Z
dc.date.issued	1999	en_US
dc.identifier.citation	Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration (1999 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846788
dc.description.abstract	Despite the growth of both the use of homeopathic drugs and the homeopathic drug industry, the Food and Drug Administration (FDA) has not altered its regulatory scheme for homeopathic drugs. As a result, homeopathic drugs are allowed on the market without any evidence that they are either safe or effective. The growing use of homeopathic drugs suggests that the FDA should reconsider its stance on homeopathic drugs so as to ensure consumer safety but yet preserve consumer choice.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	FDA	en
dc.subject	regulation	en
dc.subject	homeopathic	en
dc.subject	homeopathy	en
dc.title	Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T04:25:14Z